A detailed history of Severin Investments, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Severin Investments, LLC holds 3,805 shares of ABBV stock, worth $890,370. This represents 0.78% of its overall portfolio holdings.

Number of Shares
3,805
Previous 6,044 37.05%
Holding current value
$890,370
Previous $1.12 Billion 21.47%
% of portfolio
0.78%
Previous 1.05%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Dec 03, 2025

SELL
$184.85 - $231.54 $413,879 - $518,418
-2,239 Reduced 37.05%
3,805 $881 Million
Q2 2025

Dec 03, 2025

SELL
$170.16 - $206.27 $35,052 - $42,491
-206 Reduced 3.3%
6,044 $1.12 Billion
Q1 2025

Dec 03, 2025

BUY
$169.2 - $216.66 $21,996 - $28,165
130 Added 2.12%
6,250 $1.31 Billion
Q4 2024

Dec 03, 2025

BUY
$164.99 - $203.87 $1.01 Million - $1.25 Million
6,120 New
6,120 $1.09 Billion

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $414B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Severin Investments, LLC Portfolio

Follow Severin Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Severin Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Severin Investments, LLC with notifications on news.